miR-204-5p suppresses invasion, migration, and dissemination of PCa cells to the bone after intracardiac injection through deactivation of nuclear factor κB (NF-κB) signaling by simultaneously targeting TRAF1, TAB3, and MAP3K3 [72]. The gene discussed is TRAF1; the disease is posterior cortical atrophy.